Fiber and Prebiotic Interventions in Pediatric IBD.
Microbiome-targeted therapeutics, such as fiber and prebiotics, have the potential to restore the balance in the gut microbiome and enhance host gut health and clinical outcomes. Read more
Cost-effectiveness of fecal calprotectin used in primary care in the diagnosis of IBD
The use of Fecal Calprotectin test in primary care reduced the time to IBD diagnosis by 40 days, compared with blood testing alone. Read more
Diagnostic Delay Is Associated with Complicated Disease and Growth Impairment in Pediatric Crohn’s Disease
We aimed to determine the effect of diagnostic delay on stricturing/fistulising complications, surgery and growth impairment in a large pediatric cohort and to identify predictors of diagnostic delay. Read more
Pediatric Inflammatory Bowel Disease Among South Asians Living in British Columbia, Canada: A Distinct Clinical Phenotype
These data describe an ethnically unique clinical phenotype, where South Asian children have a higher proportion of ulcerative colitis, shorter symptom duration, more extensive colonic disease, and are more likely Read more
Vedolizumab and Anti-TNFα
Real-World Outcomes in
Biologic-Naïve IBD Patients:
Results from the EVOLVE Study
An important study looking at which biologic (vedolizumab or anti-TNF agents) is more effective and safer as a patient's first biological. Read more